-
1 Comment
Kawasumi Laboratories, Incorporated is currently in a long term uptrend where the price is trading 45.6% above its 200 day moving average.
From a valuation standpoint, the stock is 97.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Based on the above factors, Kawasumi Laboratories, Incorporated gets an overall score of 2/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| ISIN | JP3225800006 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Dividend Yield | 0.8% |
|---|---|
| Market Cap | 35B |
| PE Ratio | 26.06 |
| Target Price | 700 |
| Beta | 0.66 |
Kawasumi Laboratories, Incorporated manufactures and sells medical devices and pharmaceutical products in Japan and internationally. It offers disposable products for hemodialysis treatment, such as dialyzers, blood tubing lines, A.V. fistula needles, and isotonic sodium chloride solutions; products for plasmapheresis that include fractionators and plasma separators; blood collection and transfusion sets comprising blood bags, platelet storage bags, and potassium adsorption filters; winged blood collection sets; and thoracic stent graft systems for endovascular repair. The company was founded in 1954 and is headquartered in Tokyo, Japan. As of September 30, 2020, Kawasumi Laboratories, Incorporated operates as a subsidiary of Sumitomo Bakelite Company Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7703.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
